Knowledge of non-invasive prenatal testing among pregnant women

Susannah J Maxwell, Jan E Dickinson and Peter O’Leary
Med J Aust 2015; 203 (2): . || doi: 10.5694/mja15.00561
Published online: 20 July 2015

To the Editor: Non-invasive prenatal testing (NIPT) for trisomy 21 and other chromosomal abnormalities using cell-free fetal DNA became available in Australia on a user-pays basis in 2012.1,2 Since then, the price of this highly accurate screening test has fallen as multiple international providers entered the market, including, earlier this year, the first Australian provider.1,3 The growth in the industry and anecdotal evidence both suggest that demand for the test is increasing rapidly.

  • Susannah J Maxwell1
  • Jan E Dickinson2
  • Peter O’Leary1,3

  • 1 Curtin University, Perth, WA.
  • 2 University of Western Australia, Perth, WA.
  • 3 PathWest Laboratory Medicine, Princess Margaret Hospital, Perth, WA.


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.